Global Anti-Snoring Devices and Snoring Surgery Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Global Anti-Snoring Devices and Snoring Surgery Market Segmentation, By Device Type (Oral Appliances, Nasal Devices, Position Control Devices, Chin Straps, Tongue-stabilizing Devices, and Expiratory Positive Airway Pressure (EPAP) Therapy Devices), Surgical Procedure (Laser-assisted Uvulopalatoplasty, Radiofrequency Ablation, Pillar Procedure, Uvulopalatopharyngoplasty (UPPP), Injection Snoreplasty, Palatal Stiffening, Sclerotherapy, and Others Surgical Procedures) - Industry Trends and Forecast to 2032

Anti-Snoring Devices and Snoring Surgery Market Size

• The global anti-snoring devices and snoring surgery market size was valued at USD 24.07 billion in 2024 and is expected to reach USD 42.93 billion by 2032, at a CAGR of 7.50% during the forecast period
• The market growth is largely fueled by the increasing prevalence of sleep disorders, rising awareness about sleep health, and advancements in non-invasive and minimally invasive treatment options for snoring
• Furthermore, growing consumer preference for effective, safe, and convenient solutions to improve sleep quality is driving the adoption of anti-snoring devices and surgical interventions. These converging factors are accelerating the uptake of anti-snoring solutions, thereby significantly boosting the industry's growth

Anti-Snoring Devices and Snoring Surgery Market Analysis

• Anti-snoring devices and snoring surgery solutions, including oral appliances, nasal devices, CPAP therapy, and minimally invasive surgical procedures, are increasingly essential for managing snoring and related sleep disorders in both home and clinical settings due to their effectiveness, convenience, and improved patient compliance
• The escalating demand for anti-snoring solutions is primarily driven by the rising prevalence of sleep apnea and other sleep-related disorders, growing awareness about the health impacts of snoring, and increasing consumer preference for non-invasive and patient-friendly treatment options
• North America dominated the anti-snoring devices and snoring surgery market with the largest revenue share of 38.9% in 2024, attributed to high awareness of sleep health, advanced healthcare infrastructure, and the presence of major device manufacturers, with the U.S. seeing substantial adoption of oral appliances and minimally invasive surgeries
• Asia-Pacific is expected to be the fastest-growing region in the anti-snoring devices and snoring surgery market during the forecast period due to rising urbanization, increasing disposable incomes, and growing investments in healthcare infrastructure
• Oral appliances dominated the anti-snoring devices and snoring surgery market segment with a market share of 42.2% in 2024, driven by their proven efficacy, ease of use, and strong preference as a first-line, non-surgical treatment for snoring

Report Scope and Anti-Snoring Devices and Snoring Surgery Market Segmentation 

Anti-Snoring Devices and Snoring Surgery Market Trends

Advancements in Non-Invasive and Smart Sleep Solutions

• A significant trend in the global anti-snoring devices and snoring surgery market is the growing adoption of non-invasive, smart, and connected solutions that improve user convenience and treatment adherence

  • For instance, oral appliances integrated with Bluetooth-enabled apps can track Usage, monitor sleep patterns, and provide personalized recommendations, enhancing therapy effectiveness. Similarly, CPAP devices now come with smart features such as auto-adjustment, remote monitoring, and compatibility with mobile apps for real-time feedback

• Integration of AI and smart sensors in anti-snoring devices enables features such as predictive adjustment of airflow, detection of snoring patterns, and intelligent alerts for unusual sleep events. Devices such as the SomnoGuard and Provent EPAP incorporate these technologies to optimize comfort and treatment outcomes
• These smart solutions allow users to manage their anti-snoring therapy from a single interface, alongside other health monitoring devices, creating a more connected and proactive approach to sleep health
• The trend towards more intelligent, user-friendly, and personalized anti-snoring treatments is reshaping patient expectations, prompting companies such as ResMed and Philips Respironics to develop connected oral devices and smart CPAP systems
• The demand for anti-snoring devices with integrated digital and AI-enabled features is increasing rapidly across both home and clinical settings as consumers seek effective, convenient, and personalized treatment options

Anti-Snoring Devices and Snoring Surgery Market Dynamics

Driver

Rising Prevalence of Sleep Disorders and Growing Awareness of Sleep Health

• The increasing prevalence of sleep apnea and chronic snoring, coupled with growing awareness of the health impacts of poor sleep, is a major driver for the market

  • For instance, in March 2024, Philips Respironics launched a connected oral appliance solution with mobile app monitoring, aiming to enhance patient compliance and therapy effectiveness. Such innovations by leading companies are expected to drive market growth during the forecast period

• As patients and healthcare providers seek effective management options, anti-snoring devices and minimally invasive surgeries provide clinically validated solutions that improve sleep quality and overall health
• The convenience of home-based oral devices, CPAP therapy, and minimally invasive procedures for mild to moderate snoring further propels adoption, while integration with mobile health platforms allows better tracking and adherence
• The growing number of older adults, who are more prone to snoring and obstructive sleep apnea, is driving demand for both non-invasive devices and surgical interventions
• Improved insurance support for sleep disorder treatments and higher healthcare spending are enabling more patients to access advanced anti-snoring solutions, boosting market growth

Restraint/Challenge

Patient Compliance and Regulatory Hurdles

• A key challenge in the market is ensuring patient compliance, as inconsistent Usage of oral appliances or CPAP devices can limit treatment effectiveness. Users may experience discomfort, difficulty in adaptation, or reluctance to follow prescribed therapy, reducing long-term adoption

  • For instance, studies report that a notable percentage of CPAP users discontinue use within the first year due to discomfort or inconvenience

• Regulatory approvals and clinical validation for new devices or surgical techniques can also be time-consuming and costly, delaying market entry and adoption
• High costs of advanced devices, such as connected oral appliances or smart CPAP machines, can be a barrier in price-sensitive regions, while minimally invasive surgical procedures may be limited to specialized clinical settings
• Limited knowledge about available anti-snoring treatments in developing regions restricts market penetration and slows adoption
• Some patients experience jaw discomfort, oral irritation, or complications after surgical interventions, which may discourage Usage and hinder growth

Anti-Snoring Devices and Snoring Surgery Market Scope

The market is segmented on the basis of device type and surgical procedure.

• By Device Type

On the basis of device type, the market is segmented into oral appliances, nasal devices, position control devices, chin straps, tongue-stabilizing devices, and expiratory positive airway pressure (EPAP) Therapy Devices. Oral appliances dominated the market with the largest revenue share of 42.2% in 2024, driven by their proven efficacy, ease of use, and strong preference as a first-line, non-surgical treatment for snoring. These devices are widely recommended by sleep specialists due to their ability to reposition the jaw and tongue, reducing airway obstruction effectively. The increasing availability of customized and adjustable oral devices compatible with smart monitoring apps further boosts demand.

The Expiratory Positive Airway Pressure (EPAP) devices segment is projected to register the fastest growth in the market from 2025 to 2032, driven by rising demand for non-invasive, drug-free, and user-friendly solutions for sleep-disordered breathing. EPAP devices are compact, lightweight, and disposable, making them highly convenient for home use without the need for complex equipment. Their minimal maintenance requirements further enhance patient compliance. Additionally, the integration of EPAP systems with digital monitoring tools and mobile apps is boosting adoption, enabling real-time tracking, personalized therapy adjustments, and improved adherence rates.

• By Surgical Procedure

On the basis of surgical procedure, the market is segmented into Laser-assisted Uvulopalatoplasty, Radiofrequency Ablation, Pillar Procedure, Uvulopalatopharyngoplasty (UPPP), Injection Snoreplasty, Palatal Stiffening, Sclerotherapy, and Other Surgical Procedures. Uvulopalatopharyngoplasty (UPPP) dominated the surgical segment with a market share of 35.2% in 2024, owing to its high success rate in reducing snoring severity and treating obstructive sleep apnea. UPPP is preferred by ENT specialists for its effectiveness in removing excess tissue and widening the airway, particularly in patients with moderate to severe snoring.

The Radiofrequency Ablation segment is anticipated to emerge as the fastest-growing category in the market during the forecast period, owing to its minimally invasive approach and effectiveness in reducing airway obstructions. RFA precisely targets and shrinks soft tissues in the palate and uvula, leading to significant improvements in airflow with minimal trauma. The procedure is associated with shorter recovery times, reduced postoperative pain, and lower complication risks compared to traditional surgeries. Growing adoption in outpatient clinics and rising patient preference for safer, less invasive interventions are fueling its rapid market growth.

Anti-Snoring Devices and Snoring Surgery Market Regional Analysis

• North America dominated the anti-snoring devices and snoring surgery market with the largest revenue share of 38.9% in 2024, attributed to high awareness of sleep health, advanced healthcare infrastructure, and the presence of major device manufacturers, with the U.S. seeing substantial adoption of oral appliances and minimally invasive surgeries
• Consumers in the region highly value effective, clinically validated solutions such as oral appliances, CPAP devices, and minimally invasive surgeries, along with the convenience of home-based therapy and digital monitoring tools
• This widespread adoption is further supported by well-established healthcare systems, high disposable incomes, and the presence of leading medical device manufacturers, establishing anti-snoring devices and surgical interventions as the preferred choice for managing snoring and associated sleep disorders in both residential and clinical settings

U.S. Anti-Snoring Devices and Snoring Surgery Market Insight

The U.S. anti-snoring devices and snoring surgery market captured the largest revenue share of 82% in 2024 within North America, fueled by the high prevalence of sleep disorders and growing awareness of the health impacts of snoring. Consumers are increasingly prioritizing effective, home-based treatments such as oral appliances and CPAP devices, alongside minimally invasive surgical interventions. The rising adoption of digital health monitoring tools and mobile app integration for therapy adherence is further propelling market growth. Moreover, the availability of advanced, AI-enabled anti-snoring devices and connected solutions significantly contributes to the market's expansion.

Europe Anti-Snoring Devices and Snoring Surgery Market Insight

The Europe anti-snoring devices and snoring surgery market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by increasing awareness of sleep health and the growing prevalence of obstructive sleep apnea. The demand for minimally invasive procedures and user-friendly devices is fostering adoption across residential and clinical settings. European consumers are also drawn to technologically advanced solutions that offer convenience, real-time monitoring, and improved treatment outcomes. The market is witnessing significant growth across hospitals, sleep clinics, and home-based therapy applications.

U.K. Anti-Snoring Devices and Snoring Surgery Market Insight

The U.K. anti-snoring devices and snoring surgery market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by rising health consciousness and the desire for improved sleep quality. Concerns regarding sleep disorders and their impact on productivity and well-being are encouraging patients to adopt non-invasive anti-snoring devices and surgical solutions. The country’s well-established healthcare infrastructure, combined with the availability of connected therapy devices, is expected to continue stimulating market growth.

Germany Anti-Snoring Devices and Snoring Surgery Market Insight

The Germany anti-snoring devices and snoring surgery market is expected to expand at a considerable CAGR during the forecast period, fueled by growing awareness of sleep health, increasing prevalence of sleep apnea, and rising demand for advanced, minimally invasive treatments. Germany’s strong healthcare system and emphasis on clinical efficacy promote the adoption of both device-based and surgical anti-snoring solutions. Integration with digital monitoring tools and personalized therapy plans is becoming increasingly common in residential and clinical settings.

Asia-Pacific Anti-Snoring Devices and Snoring Surgery Market Insight

The Asia-Pacific anti-snoring devices and snoring surgery market is poised to grow at the fastest CAGR of 25% during 2025–2032, driven by rising urbanization, increasing disposable incomes, and growing awareness of sleep disorders in countries such as China, Japan, and India. The expanding healthcare infrastructure, coupled with technological advancements and government initiatives promoting health and wellness, is driving the adoption of anti-snoring devices and minimally invasive surgeries. Furthermore, increasing telemedicine and digital health solutions are enhancing accessibility and adherence to treatment.

Japan Anti-Snoring Devices and Snoring Surgery Market Insight

The Japan anti-snoring devices and snoring surgery market is gaining momentum due to the country’s high awareness of health and wellness, rapid urbanization, and demand for convenient, non-invasive sleep solutions. The adoption of anti-snoring devices is driven by the increasing number of connected health monitoring systems and integration with smart apps for tracking therapy effectiveness. In addition, Japan’s aging population is such asly to spur demand for easier-to-use, comfortable, and safe anti-snoring solutions in both home and clinical settings.

India Anti-Snoring Devices and Snoring Surgery Market Insight

The India anti-snoring devices and snoring surgery market accounted for the largest revenue share in Asia-Pacific in 2024, attributed to rising awareness of sleep health, expanding middle-class population, and increasing healthcare expenditure. Anti-snoring devices and minimally invasive surgical treatments are gaining popularity in urban and semi-urban areas. The push toward digital health adoption, availability of affordable devices, and growing number of sleep clinics are key factors propelling the market in India.

Anti-Snoring Devices and Snoring Surgery Market Share

The anti-snoring devices and snoring surgery industry is primarily led by well-established companies, including:

• Fisher & Paykel Healthcare (New Zealand)
• Koninklijke Philips N.V. (Netherlands)
• ResMed (Australia)
• SomnoMed (Australia)
• ProSomnus Sleep Technologies (U.S.)
• Zyppah (U.S.)
• Apnea Sciences (U.S.)
• Airway Management (U.S.)
• ZQuiet (U.S.)
• Smart Nora (Canada)
• Inspire Medical Systems (U.S.)
• HIVOX BIOTEK INC. (China)
• Rotech Healthcare Inc. (U.S.)
• Tomed GmbH (Germany)
• Meditas (U.S.)
• Mitsui Chemicals, Inc. (Japan)
• The Pure Sleep Company (U.S.)
• Contour Products, Inc. (U.S.)
• Sleeping Well LLC (U.S.)
• Innovative Health Technologies Inc. (U.S.)

What are the Recent Developments in Global Anti-Snoring Devices and Snoring Surgery Market?

• In December 2024, a new app-controlled device was introduced in the UK to treat sleep apnea. This implant stimulates the tongue's nerves to help sufferers breathe better overnight, offering a novel approach to managing sleep apnea
• In September 2024, dental sleep apnea treatments introduced NightLase, a non-invasive laser therapy that uses laser energy to tighten and firm the tissues in the throat, reducing airway obstruction. This procedure offers a painless alternative to traditional surgical methods, aiming to alleviate snoring and improve sleep quality
• In May 2024, Eight Sleep launched the Pod 4 mattress cover in Australia, designed to detect and prevent snoring by regulating bed temperature and providing gentle vibrations. The smart mattress cover aims to improve sleep quality by up to 32% and reduce snoring by 45%, offering a non-invasive solution for snoring issues
• In November 2022, the ProSomnus EVO [PH] sleep and snore device received FDA clearance. Designed to reduce nighttime snoring and mild to moderate obstructive sleep apnea in adults, this device uses mechanical hinge components to reposition and stabilize the patient's jaw during sleep, increasing pharyngeal space and reducing the risk of upper airway collapse
• In February 2021, the FDA authorized the eXciteOSA device, a removable tongue muscle stimulation device designed to reduce snoring and mild sleep apnea. Manufactured by Signifier Medical Technologies, eXciteOSA delivers neuromuscular stimulation to the tongue, offering a non-invasive alternative to traditional treatments

SKU-1576